Screening for cancer: are biomarkers of value?
Screening for cancer: are biomarkers of value?
Screening for cancer: are biomarkers of value?
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
– February/March 2011 34<br />
Product News<br />
STAT immunoassays <strong>for</strong> cardiac<br />
biomarker testing<br />
Roche has introduced a complete battery <strong>of</strong><br />
STAT immunoassays <strong>for</strong> cardiac biomarker<br />
testing on the cobas 6000 analyser series, the<br />
integrated system designed <strong>for</strong> diagnostic<br />
labs with medium testing volumes. With a<br />
nine-minute duration, the assays <strong>are</strong> faster<br />
than any other cardiac immunoassay tests<br />
currently available on an integrated plat<strong>for</strong>m<br />
and enable labs to deliver results to<br />
doctors treating cardiac patients in about<br />
half the time <strong>of</strong> standard Roche tests. The<br />
tests include troponin T, CK-MB, myoglobin<br />
and NT-proBNP, and <strong>are</strong> virtually<br />
equivalent to the company’s 18-minute tests<br />
in per<strong>for</strong>mance, precision and sensitivity.<br />
Roche diagnostics<br />
Mannheim, Germany<br />
www.cli-online.com & search 25485<br />
Immun<strong>of</strong>luorescence<br />
laboratory s<strong>of</strong>tw<strong>are</strong><br />
A complete<br />
system <strong>for</strong> the<br />
management <strong>of</strong><br />
autoimmune IF<br />
lab procedures,<br />
the i-mLS is an<br />
extremely userfriendly<br />
s<strong>of</strong>tw<strong>are</strong><br />
that provides a high level <strong>of</strong> control <strong>of</strong> all<br />
aspects <strong>of</strong> autoimmune IF testing. Designed<br />
to be the ideal companion <strong>for</strong> the I-mLD<br />
microscope, the s<strong>of</strong>tw<strong>are</strong> enables users to<br />
capture and store microscope images and to<br />
create a customised image catalogue <strong>for</strong> use<br />
as a reference. The s<strong>of</strong>tw<strong>are</strong> also allows easy<br />
result reporting and the addition <strong>of</strong> comments<br />
from the analyst, which can be introduced<br />
either into the basic system or into<br />
a report <strong>for</strong>mat. In addition, the s<strong>of</strong>tw<strong>are</strong><br />
enables the inclusion <strong>of</strong> additional in<strong>for</strong>mation<br />
such as clinical comments and images<br />
<strong>of</strong> patient tests, the consultation <strong>of</strong> results<br />
by patient, test or session, as well as communication<br />
with the LIS. When connected<br />
to the i-Pro immun<strong>of</strong>luorescence processor,<br />
the i-mLS s<strong>of</strong>tw<strong>are</strong> can import current session<br />
in<strong>for</strong>mation, read results at the microscope<br />
and then export data back to the i-Pro<br />
in<strong>for</strong>mation on a new working session with<br />
new or repeat test request. The system also<br />
allows laboratory managers to maintain<br />
traceability <strong>of</strong> reagents used in all tests per<strong>for</strong>med<br />
on the i-Pro and to remotely access<br />
stored results from their own <strong>of</strong>fice.<br />
BioSystems<br />
Barcelona, Spain<br />
www.cli-online.com & search 25484<br />
Platelet disfunction test system<br />
The next-generation <strong>of</strong> Siemens’ best-in-class<br />
technology to detect inherited, acquired, and<br />
drug-induced platelet dysfunction, the new<br />
INNOVANCE PFA 200 system has userfriendly<br />
updates including a colour LCD<br />
touchscreen to access detailed patient and<br />
result in<strong>for</strong>mation, a barcode reader <strong>for</strong> digital<br />
patient result tracking and LIS connection,<br />
and a USB port to archive stored data. The<br />
system also has multiple user-friendly s<strong>of</strong>tw<strong>are</strong><br />
updates, including new s<strong>of</strong>tw<strong>are</strong> that<br />
supports closure curve illustrations <strong>for</strong> use in<br />
scientific studies. Results, which <strong>are</strong> avaiable<br />
in 4-8 minutes, allow rapid comprehensive<br />
bleeding assessment. The system carries out<br />
collagen/EPI and collagen/ADP tests and the<br />
company’s latest addition, the P2Y test <strong>for</strong><br />
detection <strong>of</strong> platelet P2Y12-receptor blockades<br />
in patients.<br />
Siemens Medical Solutions<br />
Diagnostics<br />
Tarrytown, NY, USA<br />
www.cli-online.com & search 25514<br />
Vitamin D control<br />
Now available throughout the European<br />
Union, Fujirebio Diagnostics’ Vitamin D<br />
Control contains both 25(OH) Vitamin D2<br />
and 25(OH) Vitamin D3, and is intended<br />
<strong>for</strong> use as a quantitative, assayed serum<br />
control. The control has excellent stability,<br />
<strong>value</strong> assignment across plat<strong>for</strong>ms and<br />
clinically relevant levels, enabling laboratories<br />
to monitor the per<strong>for</strong>mance <strong>of</strong> their<br />
vitamin D assays.<br />
Fujirebio diagnostics<br />
Malvern, PA, USA<br />
www.cli-online.com & search 25487<br />
Calendar <strong>of</strong> events<br />
May 7-10, 2011<br />
21st ECCMID / 27th ICCs<br />
Milan, Italy<br />
Tel. +41 61 686 77 11<br />
Fax +41 61 686 77 88<br />
e-mail: eccmid@escmid.org<br />
www.eccmid-icc2011.org<br />
May 9-13, 2011<br />
4th International Congress <strong>of</strong><br />
Myology<br />
Lille, France<br />
Tel. +33 4 78 176 276<br />
http://myology2011.org/<br />
index_us.html<br />
May 13-15, 2011<br />
XIIth International Congress <strong>of</strong><br />
Paediatric Laboratory Medicine<br />
(ICPLM)<br />
Berlin, Germany<br />
Tel. +39 0266802323<br />
e-mail: icplm2011@mzcongressi.com<br />
www.icplm2011.org/<br />
May 15-19, 2011<br />
IFCC-Worldlab-Euromedlab<br />
Berlin 2011 Congress<br />
Berlin, Germany<br />
Tel. +39 02 66802323<br />
Fax +39 02 6686699<br />
e-mail: info@berlin2011.org<br />
www.berlin2011.org<br />
May 23-26, 2011<br />
FOCUS 2011<br />
Harrogate, UK<br />
Tel. +44 141 434 1500<br />
Fax +44 141 434 1519<br />
e-mail: focus2011@meetingmakers.co.uk<br />
www.focus-acb.org.uk<br />
May 24-27, 2011<br />
Hospitalar 2011<br />
São Paulo, Brazil<br />
www.hospitalar.com/ingles/<br />
June 25-29, 2011<br />
10th World Congress on<br />
Inflammation<br />
Paris, France<br />
Tel. 33 1 53 85 82 71<br />
Fax 33 1 53 85 82 83<br />
Email:<br />
info@inflammation2011.com<br />
www.inflammation2011.com<br />
July 17-20, 2011<br />
6th IAS Conference on HIV<br />
Pathogenesis, Treatment and<br />
Prevention<br />
Rome, Italy<br />
www.ias2011.org<br />
July 24-28, 2011<br />
2011 AACC Annual Meeting<br />
Atlanta, GA, USA<br />
www.aacc.org/<br />
events/2011am/<br />
September 21-24, 2011<br />
14th Annual Meeting <strong>of</strong> the<br />
European Society <strong>for</strong> Clinical<br />
Virology (ESCV)<br />
Funchal, Madeira, Portugal<br />
www.escv.org/meetings/meetings.asp<br />
October 2-6, 2011<br />
12th International Congress <strong>of</strong><br />
Therapeutic Drug Monitoring<br />
and Clinical Toxicology<br />
Stuttgart, Germany<br />
Tel. +49 711 8931 636<br />
Fax +49 711 8931 370<br />
e-mail: info@iatdmct2011.de<br />
www.iatdmct2011.de<br />
October 15 – 16, 2011<br />
The Lancet / ESCMID Conference<br />
on Healthc<strong>are</strong>-Associated<br />
Infections and Antimicrobial<br />
Resistance<br />
Beijing, China<br />
Tel. +86 21 61333077<br />
Fax +86 21 52980210<br />
e-mail: summitenquiry@elsevier.com<br />
October 24–26, 2011<br />
ESCMID Conference on<br />
Diagnosing Infectious Diseases:<br />
Future and Innovation<br />
Venice, Italy<br />
Tel. +39 041 52 62 530<br />
Fax +39 041 52 71 129<br />
e-mail: ico@icorganization.it<br />
www.escmid.org<br />
For more events see:<br />
www.cli-online.com/events/<br />
Dates and descriptions <strong>of</strong> future<br />
events have been obtained from<br />
<strong>of</strong>ficial industrial sources. CLi cannot<br />
be held responsible <strong>for</strong> errors,<br />
changes or cancellations.